Current Neuro-Oncology
Volume
4 Number 7
31 July 2002
Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 7, 31 July
Lee JY, Niranjan A, McInerney J,
Kondziolka D, Flickinger JC, Lunsford LD.
Stereotactic
radiosurgery providing long-term tumor control of cavernous sinus
meningiomas.
J
Neurosurg. 2002 Jul;97(1):65-72∟.
doi: 10.3171/jns.2002.97.1.0065∟.
PMID: 12134934∟.
Observational study. ˍ
Philipson MR, Timothy J,
Chakrobarthy A, Towns G.
Pilocytic
astrocytoma of a spinal nerve root. Case report.
J
Neurosurg. 2002 Jul;97(1 Suppl):110-2∟.
doi: 10.3171/spi.2002.97.1.0110∟.
PMID: 12120632∟.
Case report. ˍ
Zander T, Nettekoven W, Kraus JA,
Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
Intensified
PCV-chemotherapy with optional stem cell support in recurrent
malignant oligodendroglioma.
J
Neurol. 2002 Jul;249(8):1055-7∟.
doi: 10.1007/s00415-002-0794-1∟.
PMID: 12195453∟.
Observational study. ˍ
Crews KR, Stewart CF, Jones-Wallace
D, Thompson SJ, Houghton PJ, Heideman RL, Fouladi M, Bowers DC,
Chintagumpala MM, Gajjar A.
Altered
irinotecan pharmacokinetics in pediatric high-grade glioma
patients receiving enzyme-inducing anticonvulsant therapy.
Clin
Cancer Res. 2002 Jul 1;8(7):2202-9∟.
PMID: 12114421∟.
Interventional study. ˍ
Sklar CA, Mertens AC, Mitby P,
Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL.
Risk
of disease recurrence and second neoplasms in survivors of
childhood cancer treated with growth hormone: a report from the
Childhood Cancer Survivor Study.
J
Clin Endocrinol Metab. 2002 Jul 1;87(7):3136-41∟.
doi: 10.1210/jcem.87.7.8606∟.
PMID: 12107213∟.
Observational study. ˍ
Becker R, Eichler MK, Jennemann R,
Bertalanffy H.
Phase
I clinical trial on adjuvant active immunotherapy of human gliomas
with GD2-conjugate.
Br
J Neurosurg. 2002 Jul 6;16(3):269-75∟.
doi: 10.1080/02688690220148860∟.
PMID: 12201397∟.
Interventional study. ˍ
Postma TJ, Klein M, Verstappen CC,
Bromberg JE, Swennen M, Langendijk JA, Taphoorn MJ, Scheltens P,
Slotman BJ, van der Ploeg HM, Aaronson NK, Heimans
JJ.
Radiotherapy-induced
cerebral abnormalities in patients with low-grade
glioma.
Neurology.
2002 Jul 9;59(1):121-3∟.
doi: 10.1212/wnl.59.1.121∟.
PMID: 12105319∟.
Observational study. ˍ
Riva D, Giorgi C, Nichelli F,
Bulgheroni S, Massimino M, Cefalo G, Gandola L, Giannotta M,
Bagnasco I, Saletti V, Pantaleoni C.
Intrathecal
methotrexate affects cognitive function in children with
medulloblastoma.
Neurology.
2002 Jul 9;59(1):48-53∟.
doi: 10.1212/wnl.59.1.48∟.
PMID: 12105306∟.
Observational study. ˍ
Fulda S, Wick W, Weller M, Debatin
KM.
Smac
agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced
apoptosis and induce regression of malignant glioma in vivo.
Nat
Med. 2002 Jul 15;8(8):808-15∟.
doi: 10.1038/nm735∟.
PMID: 12118245∟.
Laboratory investigation. ˍ
Kleinberg L, Grossman SA, Carson K,
Lesser G, O'Neill A, Pearlman J, Phillips P, Herman T, Gerber
M.
Survival
of patients with newly diagnosed glioblastoma multiforme treated
with RSR13 and radiotherapy: results of a phase II new approaches
to brain tumor therapy CNS consortium safety and efficacy study.
J
Clin Oncol. 2002 Jul 15;20(14):3149-55∟.
doi: 10.1200/JCO.2002.01.096∟.
PMID: 12118029∟.
Interventional study. ˍ
Singh H, Maurya V, Gill
SS.
Computerised
Tomography Features in Gliomas.
Med
J Armed Forces India. 2002 Jul 21;58(3):221-5∟.
doi: 10.1016/S0377-1237(02)80134-4∟.
PMID: 27407387∟.
Observational study. ˍ
Kellie SJ, Wong CK, Pozza LD,
Waters KD, Lockwood L, Mauger DC, White L.
Activity
of postoperative carboplatin, etoposide, and high-dose
methotrexate in pediatric CNS embryonal tumors: results of a phase
II study in newly diagnosed children.
Med
Pediatr Oncol. 2002 Jul 23;39(3):168-74∟.
doi: 10.1002/mpo.10137∟.
PMID: 12210445∟.
Interventional study. ˍ
McNeil DE, Coté TR, Clegg L, Rorke LB.
Incidence
and trends in pediatric malignancies
medulloblastoma/primitive neuroectodermal tumor: a SEER update.
Surveillance Epidemiology and End
Results.
Med Pediatr Oncol. 2002 Jul
23;39(3):190-4∟.
doi: 10.1002/mpo.10121∟.
PMID: 12210449∟.
Observational study. ˍ